FormWeb • clarithromycin

Oregon Department of Corrections

Approved Formulary

Webpage Links

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

clarithromycin

clarithromycin

Formulary Duration Restrictions Limited to 6 weeks without TLC approval.
Cell Status Approved

Brand names: Biaxin

Form	Strength
TABLET, ORAL	250 mg; 500 mg

Last updated: Aug. 23, 2021

FDA Drug Safety: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Biaxin Filmtab (clarithromycin tablets, USP), Biaxin XL Filmtab (clarithromycin extended-release tablets), Biaxin Granules (clarithromycin for oral suspension, USP)

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.